HYUNDAI BIOLAND Co.,Ltd. Logo

HYUNDAI BIOLAND Co.,Ltd.

Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.

052260 | KO

Overview

Corporate Details

ISIN(s):
KR7052260007
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HYUNDAI BIOLAND Co., Ltd. is a comprehensive healthcare and biotechnology company specializing in the research, development, and manufacturing of biomaterials derived from natural resources. The company's core business operates across three main sectors: cosmetics, nutraceuticals (health supplements), and regenerative medicine. It is a key supplier of raw materials, including collagen and hyaluronic acid, to the cosmetics industry. In the nutraceuticals field, it provides functional ingredients for health foods. For the biomedical market, the company develops medical devices such as resorbable membranes for dental and periodontal tissue regeneration. Leveraging its position as a leading natural materials company in Korea, Hyundai Bioland distributes its products to over 35 countries, with safety certifications in 33 nations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Regulatory News Service
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 7.7 KB
2025-08-26 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-04 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-28 00:00
Report Publication Announcement
결산실적공시예고
Korean 3.6 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 134.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.1 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-28 00:00
Report Publication Announcement
결산실적공시예고
Korean 3.6 KB
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 33.4 KB
2025-03-12 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 30.3 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 27.1 KB
2025-03-11 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 467.3 KB

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOLAND Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HYUNDAI BIOLAND Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HYUNDAI BIOLAND Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.